Cryopreservation of Ovarian Tissue in Pediatric Patients

Table 2

Characteristics of the pre-chemotherapy patients who had ovarian tissue cryopreservation.

No.	Pathology	Age (months)	D/mm^2 (RO)	D/mm^2  (LO)	Cryopreserved fragments No.
1	Wilms tumor	53	49.89	—	63
2	Shwachmann syndrome	118	58.83	24.05	10
3	Ewing sarcoma	78	36.92	39.04	10
4	Ewing sarcoma	120	64.02	102.77	15
5	Hodgkin lymphoma	161	11.51	16.53	23
6	Hodgkin lymphoma	177	31.8	13.59	44
7	Hodgkin lymphoma	182	11.26	1.00	14
8	Hodgkin lymphoma	195	90.80	44.28	10
9	Non-Hodgkin lymphoma	205	1.92	1.74	9
10	Hodgkin lymphoma	206	12.18	15.64	14
11	Ewing sarcoma	144	159.24	26.30	11
12	Ewing sarcoma	173	0.69	1.58	16
13	Ewing sarcoma	184	18.41	15.45	23
14	Ewing sarcoma	190	3.20	11.84	21
15	Bone marrow aplasia	152	14.68	15.12	45
16	Bone marrow aplasia	160	14.47	10.37	38
17	Myelodisplasia	152	4.07	11.26	17
18	Mixoide tumor	203	15.47	8.01	16
19	Thalassemia major	180	9.98	17.80	22
20	Thalassemia major	193	2.58	6.96	33
21	Hodgkin lymphoma	214	18.24	13.87	12
22	Systemic lupus Erythematosus	198	1.87	1.66	33

No. 1–4 premenarcheal patients, No. 5–22 postmenarcheal patients.
D/mm²: follicle density per mm².
RO: right ovary; LO: left ovary.